Phone: (650) 368 6983
info@airmid.com

Sitemap

Home

About us	Overview
	Background
	The Team	Board of directors :

		George Miljanich
		Marc Schneidman
		George Chandy

		Drug Development Committee :

		Michael Pennington
		Heike Wulff
		George Shopp
		Christine Beeton
		Jan Wallace

		Clinical Advisory Board :

		Gerold Nepom
		Peter Calabresi
		Jerry McCullough

		Other Founders :

		Michael Cahalan
		Raymond Norton
		George Gutman
		Katalin Kalman
		Evan Gruber

Research and development	Target Portfolio	Unment Needs
		AIRMID’s Novel Therapeutic Approach
		AIRMIDs Therapeutics
		Excellent Safety Profiles
		Proof-of-concept AIRMID Technology

	Key Publications
	Development Strategies

Press

Contact

Autoimmune disease

Multiple sclerosis

Type 1 diabetes mellitus

Kv1.3 Potassium Channel

PAP-1

ShK

Effector memory T cells

October 2006

AIRMID receives Series A
financing from Biotechnology
Value Fund.

more...